| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
787,100,000 |
| Market
Cap: |
85.20(B) |
| Last
Volume: |
191,226,646 |
Avg
Vol: |
89,536,962 |
| 52
Week Range: |
$108.24 - $108.24 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
| |
NASDAQ COMPOSITE |
|
NASDAQ-100 |
| |
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Reicin Alise |
PRES., GLOBAL CLINICAL DEV. |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(44,615) |
0 |
|
- |
|
| Reicin Alise |
PRES., GLOBAL CLINICAL DEV. |
• – – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
37,434 |
44,615 |
|
- |
|
| Ahmed Nadim |
PRES., GLOBAL HEM. AND ONC. |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,966) |
0 |
|
- |
|
| Ahmed Nadim |
PRES., GLOBAL HEM. AND ONC. |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(40,694) |
0 |
|
- |
|
| Ahmed Nadim |
PRES., GLOBAL HEM. AND ONC. |
• – – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
25,875 |
40,694 |
|
- |
|
| Curran Terrie |
PRES., GLBL INFLAM. AND IMMUN. |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(327) |
0 |
|
- |
|
| Curran Terrie |
PRES., GLBL INFLAM. AND IMMUN. |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(37,181) |
0 |
|
- |
|
| Curran Terrie |
PRES., GLBL INFLAM. AND IMMUN. |
• – – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
32,868 |
37,181 |
|
- |
|
| Haller Julia A |
|
– • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,409) |
0 |
|
- |
|
| Loughlin James J |
|
– • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,800) |
0 |
|
- |
|
| Loughlin James J |
|
– • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(41,861) |
0 |
|
- |
|
| Vessey Rupert |
PRES., RESEARCH AND EARLY DEV. |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(613) |
0 |
|
- |
|
| Vessey Rupert |
PRES., RESEARCH AND EARLY DEV. |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(60,927) |
0 |
|
- |
|
| Vessey Rupert |
PRES., RESEARCH AND EARLY DEV. |
• – – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
46,749 |
60,927 |
|
- |
|
| Elkins David V |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(195) |
0 |
|
- |
|
| Elkins David V |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(57,132) |
0 |
|
- |
|
| Elkins David V |
EVP, CHIEF FINANCIAL OFFICER |
• – – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
43,224 |
57,132 |
|
- |
|
| Biller Jonathan |
EVP AND GENERAL COUNSEL |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(878) |
0 |
|
- |
|
| Biller Jonathan |
EVP AND GENERAL COUNSEL |
• – – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,652) |
0 |
|
- |
|
| Biller Jonathan |
EVP AND GENERAL COUNSEL |
• – – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
20,387 |
26,652 |
|
- |
|
| Friedman Michael A |
|
– • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(19,847) |
0 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,252) |
0 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(366,495) |
0 |
|
- |
|
| Alles Mark J |
CEO, CHAIRMAN OF BOARD |
• • – |
2019-11-20 |
4 |
A |
$0.00 |
$0 |
D/D |
145,229 |
366,495 |
|
- |
|
| Cox Carrie Smith |
|
– • – |
2019-11-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(39,535) |
0 |
|
- |
|
956 Records found
|
|
Page 1 of 39 |
|
|
